{"id":38269,"date":"2026-08-26T12:17:14","date_gmt":"2026-08-26T12:17:14","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=38269"},"modified":"2026-08-26T12:17:14","modified_gmt":"2026-08-26T12:17:14","slug":"takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/","title":{"rendered":"\u6b66\u7530\u85ac\u54c1\u306e\u300cORZEYFUL\u300d\u306e\u627f\u8a8d\u306f\u3001\u65e5\u672c\u306e\u30cb\u30e5\u30fc\u30ed\u30c6\u30c3\u30af\u7523\u696d\u306b\u3068\u3063\u3066\u65b0\u305f\u306a\u7bc0\u76ee\u3068\u306a\u308a\u307e\u3059"},"content":{"rendered":"

\u539a\u751f\u52b4\u50cd\u7701\u304c\u6b66\u7530\u85ac\u54c1\u5de5\u696d\u304c\u88fd\u9020\u3059\u308b\u300c\u30aa\u30eb\u30bc\u30a4\u30d5\u30eb\u300d\u3068\u3044\u3046\u533b\u85ac\u54c1\u3092\u627f\u8a8d\u3057\u305f\u3053\u3068\u3092\u53d7\u3051\u3001\u65e5\u672c\u306e\u533b\u85ac\u54c1\u30fb\u30d8\u30eb\u30b9\u30b1\u30a2\u6280\u8853\u7523\u696d\u306f\u65b0\u305f\u306a\u5c55\u958b\u306e\u6642\u4ee3\u3092\u8fce\u3048\u3088\u3046\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u533b\u85ac\u54c1\u306f\u3001\u7b2c1\u578b\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc\u3068\u3044\u3046\u75be\u60a3\u3092\u6301\u3064\u6210\u4eba\u3092\u5bfe\u8c61\u3068\u3057\u305f\u3082\u306e\u3067\u3059\u3002.<\/p>

The approval came out on August 24 2026. It is very important because ORZEYFUL is the medicine of its kind that is taken by mouth. It works on a part of the brain called the orexin receptor 2. This medicine helps with the root cause of the condition, which’s a lack of orexin. It does not just treat the symptoms. The medicine was created by scientists at Takeda in Japan. This approval shows that research, from Japan can lead to a medicine that is used by patients.
\nThe development could have implications beyond Takeda. It highlights Japan’s continuing strength in drug discovery, neuroscience research and advanced pharmaceutical development, while potentially creating opportunities for businesses involved in clinical research, digital health, diagnostics and healthcare technology.<\/p>

ORZEYFUL\u3001\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc\u6cbb\u7642\u3078\u306e\u65b0\u305f\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u3092\u767a\u8868<\/h3>

Japan’s pharmaceutical and healthcare technology sectors are entering a phase of innovation after the Japanese Ministry of Health Labour and Welfare approved Takeda Pharmaceutical’s ORZEYFUL for adults with narcolepsy type 1.<\/p>

\u7b2c1\u578b\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc\u306f\u3001\u899a\u9192\u3068\u7761\u7720\u306e\u8abf\u7bc0\u306b\u95a2\u4e0e\u3059\u308b\u795e\u7d4c\u30da\u30d7\u30c1\u30c9\u3067\u3042\u308b\u30aa\u30ec\u30ad\u30b7\u30f3\u306e\u6b20\u4e4f\u3092\u7279\u5fb4\u3068\u3059\u308b\u3001\u307e\u308c\u306a\u795e\u7d4c\u75be\u60a3\u3067\u3059\u3002\u7b2c1\u578b\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc\u306e\u60a3\u8005\u3055\u3093\u306f\u3001\u65e5\u4e2d\u306e\u7720\u6c17\u3001\u30ab\u30bf\u30d7\u30ec\u30af\u30b7\u30fc\u3001\u591c\u9593\u306e\u7761\u7720\u969c\u5bb3\u306a\u3069\u306e\u75c7\u72b6\u306b\u60a9\u307e\u3055\u308c\u3001\u5b66\u6821\u3084\u4ed5\u4e8b\u3001\u65e5\u5e38\u751f\u6d3b\u306b\u652f\u969c\u3092\u304d\u305f\u3059\u3053\u3068\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>

\u6b66\u7530\u85ac\u54c1\u306b\u3088\u308b\u3068\u3001\u300cORZEYFUL\u300d\u306fOX2R\u53d7\u5bb9\u4f53\u3092\u7279\u7570\u7684\u306b\u6d3b\u6027\u5316\u3057\u3001\u30aa\u30ec\u30ad\u30b7\u30f3\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u306e\u56de\u5fa9\u3092\u52a9\u3051\u308b\u3068\u306e\u3053\u3068\u3067\u3059\u3002\u300cORZEYFUL\u300d\u306f\u3001\u4e16\u754c\u898f\u6a21\u3067\u5b9f\u65bd\u3055\u308c\u305f\u7b2c3\u76f8\u81e8\u5e8a\u8a66\u9a13\u300cFirstLight\u300d\u304a\u3088\u3073\u300cRadiantLight\u300d\u306b\u304a\u3044\u3066\u3001\u65e5\u4e2d\u306e\u7720\u6c17\u3084\u30ab\u30bf\u30d7\u30ec\u30af\u30b7\u30fc\u306a\u3069\u3001\u7b2c1\u578b\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc\u306e\u3044\u304f\u3064\u304b\u306e\u75c7\u72b6\u306b\u304a\u3044\u3066\u7d71\u8a08\u7684\u306b\u6709\u610f\u306a\u6539\u5584\u304c\u8a8d\u3081\u3089\u308c\u305f\u3053\u3068\u3092\u53d7\u3051\u3001\u627f\u8a8d\u3055\u308c\u307e\u3057\u305f\u3002.<\/p>

\u4eca\u56de\u306e\u627f\u8a8d\u306f\u3001\u4e2d\u56fd\u304a\u3088\u3073\u7c73\u56fd\u3067\u306e\u627f\u8a8d\u306b\u7d9a\u304d\u3001\u300cORZEYFUL\u300d\u306b\u3068\u3063\u3066\u91cd\u8981\u306a\u898f\u5236\u5f53\u5c40\u306e\u627f\u8a8d\u3068\u306a\u308a\u307e\u3059\u3002.<\/p>

For Japan’s pharmaceutical industry this event is more than a product launch. It shows that long‑term investment, in neuroscience can eventually create a whole new class of therapies.
\n\u65e5\u672c\u306e\u7814\u7a76\u958b\u767a\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u306f\u3001ORZEYFUL\u306e\u6210\u529f\u304b\u3089\u6069\u6075\u3092\u53d7\u3051\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002ORZEYFUL\u306e\u6210\u529f\u306f\u3001\u65e5\u672c\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u304a\u3088\u3073\u88fd\u85ac\u7814\u7a76\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u3078\u306e\u95a2\u5fc3\u3092\u9ad8\u3081\u308b\u304b\u3082\u3057\u308c\u307e\u305b\u3093\u3002.<\/p>

\u5275\u85ac\u306f\u3001\u9ad8\u5ea6\u306a\u5b9f\u9a13\u5ba4\u6280\u8853\u3001\u8a08\u7b97\u751f\u7269\u5b66\u3001\u81e8\u5e8a\u8a66\u9a13\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3001\u304a\u3088\u3073\u30c7\u30fc\u30bf\u5206\u6790\u306b\u307e\u3059\u307e\u3059\u4f9d\u5b58\u3059\u308b\u3088\u3046\u306b\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u65e5\u672c\u306e\u88fd\u85ac\u4f1a\u793e\u306f\u3001\u795e\u7d4c\u75be\u60a3\u3084\u5e0c\u5c11\u75be\u60a3\u306e\u6cbb\u7642\u6cd5\u3092\u63a2\u6c42\u3057\u3066\u3044\u307e\u3059\u3002\u7814\u7a76\u958b\u767a\u3092\u652f\u3048\u308b\u6280\u8853\u306b\u5bfe\u3059\u308b\u9700\u8981\u306f\u3001\u4eca\u5f8c\u9ad8\u307e\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>

\u4eba\u5de5\u77e5\u80fd\u3082\u307e\u305f\u3001\u5927\u304d\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u3046\u308b\u5206\u91ce\u306e\u4e00\u3064\u3067\u3059\u3002AI\u3084\u6a5f\u68b0\u5b66\u7fd2\u306f\u3001\u7814\u7a76\u8005\u304c\u30c7\u30fc\u30bf\u30bb\u30c3\u30c8\u3092\u5206\u6790\u3057\u3001\u751f\u7269\u5b66\u7684\u30d1\u30bf\u30fc\u30f3\u3092\u7279\u5b9a\u3057\u3001\u6709\u671b\u306a\u5275\u85ac\u5019\u88dc\u3092\u898b\u3064\u3051\u308b\u30d7\u30ed\u30bb\u30b9\u3092\u6539\u5584\u3059\u308b\u306e\u306b\u5f79\u7acb\u3061\u307e\u3059\u3002ORZEYFUL\u306e\u79d1\u5b66\u7684\u767a\u898b\u305d\u306e\u3082\u306e\u306fAI\u306b\u3088\u3063\u3066\u3082\u305f\u3089\u3055\u308c\u305f\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u3057\u304b\u3057\u3001\u5927\u624b\u88fd\u85ac\u696d\u754c\u3067\u306f\u3001\u958b\u767a\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u3092\u901a\u3058\u3066\u3053\u3046\u3057\u305f\u6280\u8853\u306e\u5229\u7528\u304c\u307e\u3059\u307e\u3059\u5e83\u304c\u3063\u3066\u3044\u307e\u3059\u3002.<\/p>

\u3053\u308c\u306b\u3088\u308a\u3001\u65e5\u672c\u306e\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306f\u3001\u533b\u7642\u5206\u91ce\u3068\u5207\u308a\u96e2\u3057\u3066\u6d3b\u52d5\u3059\u308b\u306e\u3067\u306f\u306a\u304f\u3001\u4f01\u696d\u3068\u9023\u643a\u3059\u308b\u6a5f\u4f1a\u3092\u5f97\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002.<\/p>

\u5e0c\u5c11\u75be\u60a3\u306f\u3001\u3088\u308a\u5927\u304d\u306a\u6280\u8853\u5e02\u5834\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059<\/h3>

ORZEYFUL\u306f\u307e\u305f\u3001\u5e0c\u5c11\u75be\u60a3\u306e\u7814\u7a76\u304c\u65e5\u672c\u306e\u30d3\u30b8\u30cd\u30b9\u306b\u3068\u3063\u3066\u3044\u304b\u306b\u91cd\u8981\u3067\u3042\u308b\u304b\u306b\u3064\u3044\u3066\u3082\u6307\u6458\u3057\u3066\u3044\u307e\u3059\u3002.<\/p>

I see that making drugs for rare diseases is hard. Trials need people and data that lasts a long time. Digital tools can help drug makers find the patients keep track from far away and gather real‑world evidence after a drug is sold.<\/p>

\u533b\u7642\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u4f01\u696d\u306f\u3001\u5e0c\u5c11\u75be\u60a3\u306e\u30ec\u30b8\u30b9\u30c8\u30ea\u3001\u81e8\u5e8a\u8a66\u9a13\u7ba1\u7406\u3001\u9060\u9694\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3001\u30c7\u30fc\u30bf\u5171\u6709\u3068\u3044\u3063\u305f\u5206\u91ce\u306b\u30d3\u30b8\u30cd\u30b9\u30c1\u30e3\u30f3\u30b9\u3092\u898b\u51fa\u3059\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002.<\/p>

\u5e0c\u5c11\u75be\u60a3\u306f\u3001\u88fd\u85ac\u4f1a\u793e\u3001\u75c5\u9662\u3001\u5927\u5b66\u3001\u305d\u3057\u3066\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306e\u9593\u3067\u3001\u3088\u308a\u7dca\u5bc6\u306a\u9023\u643a\u3092\u3082\u305f\u3089\u3059\u53ef\u80fd\u6027\u304c\u3042\u308b\u3068\u601d\u3044\u307e\u3059\u3002.
\n\u65e5\u672c\u306e\u7814\u7a76\u958b\u767a\u74b0\u5883\u306f\u3001\u3053\u306e\u3053\u3068\u304b\u3089\u591a\u304f\u306e\u6069\u6075\u3092\u53d7\u3051\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3067\u3057\u3087\u3046\u3002.<\/p>

ORZEYFUL\u306e\u6210\u529f\u306f\u3001\u65e5\u672c\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u304a\u3088\u3073\u88fd\u85ac\u7814\u7a76\u74b0\u5883\u3078\u306e\u95a2\u5fc3\u3092\u9ad8\u3081\u308b\u304d\u3063\u304b\u3051\u3068\u306a\u308b\u304b\u3082\u3057\u308c\u307e\u305b\u3093\u3002.<\/p>

\u533b\u85ac\u54c1\u306e\u958b\u767a\u306f\u3001\u9ad8\u5ea6\u306a\u5b9f\u9a13\u6a5f\u5668\u3001\u30b3\u30f3\u30d4\u30e5\u30fc\u30bf\u3092\u6d3b\u7528\u3057\u305f\u751f\u7269\u5b66\u3001\u81e8\u5e8a\u8a66\u9a13\u30b7\u30b9\u30c6\u30e0\u3001\u305d\u3057\u3066\u30c7\u30fc\u30bf\u89e3\u6790\u3078\u306e\u4f9d\u5b58\u5ea6\u304c\u9ad8\u307e\u308a\u3064\u3064\u3042\u308a\u307e\u3059\u3002\u65e5\u672c\u306e\u88fd\u85ac\u4f01\u696d\u304c\u8133\u75be\u60a3\u3084\u5e0c\u5c11\u75be\u60a3\u306e\u6cbb\u7642\u6cd5\u3092\u6a21\u7d22\u3059\u308b\u4e2d\u3001\u7814\u7a76\u958b\u767a\u3092\u652f\u3048\u308b\u5c02\u9580\u7684\u306a\u30c4\u30fc\u30eb\u306e\u9700\u8981\u306f\u3055\u3089\u306b\u9ad8\u307e\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>

Artificial intelligence is also an area of influence. AI and learning machines can help scientists look at data find biological signs and make the process of finding new medicine better. Even though AI didn’t lead to the discovery behind ORZEYFUL, the whole drug industry is using computer-based tools more and more during the development steps.<\/p>

\u3053\u308c\u306b\u3088\u308a\u3001\u65e5\u672c\u306e\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306b\u3068\u3063\u3066\u3001\u30d8\u30eb\u30b9\u30b1\u30a2\u5206\u91ce\u3068\u306f\u4e00\u7dda\u3092\u753b\u3057\u305f\u533b\u85ac\u54c1\u4f01\u696d\u3068\u63d0\u643a\u3059\u308b\u6a5f\u4f1a\u304c\u751f\u307e\u308c\u307e\u3059\u3002.<\/p>

\u5e0c\u5c11\u75be\u60a3\u306f\u3001\u3088\u308a\u5927\u304d\u306a\u6280\u8853\u5e02\u5834\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059<\/h3>

\u307e\u305f\u3001ORZEYFUL\u306f\u3001\u65e5\u672c\u306b\u304a\u3051\u308b\u5e0c\u5c11\u75be\u60a3\u306e\u7814\u7a76\u306e\u91cd\u8981\u6027\u3092\u5f37\u8abf\u3057\u3066\u3044\u307e\u3059\u3002.<\/p>

\u7279\u5b9a\u306e\u96c6\u56e3\u3092\u5bfe\u8c61\u3068\u3057\u305f\u533b\u85ac\u54c1\u306e\u958b\u767a\u306f\u56f0\u96e3\u3067\u3059\u3002\u305d\u306e\u7406\u7531\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u60a3\u8005\u3092\u7279\u5b9a\u3059\u308b\u65b9\u6cd5\u3084\u3001\u9577\u671f\u306b\u308f\u305f\u3063\u3066\u30c7\u30fc\u30bf\u3092\u53ce\u96c6\u3059\u308b\u4ed5\u7d44\u307f\u304c\u5fc5\u8981\u3068\u306a\u308b\u305f\u3081\u3067\u3059\u3002\u30c7\u30b8\u30bf\u30eb\u6280\u8853\u306f\u3001\u88fd\u85ac\u4f01\u696d\u304c\u60a3\u8005\u3092\u7279\u5b9a\u3059\u308b\u4e0a\u3067\u5f79\u7acb\u3064\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u307e\u305f\u3001\u533b\u85ac\u54c1\u304c\u5e02\u5834\u306b\u6295\u5165\u3055\u308c\u305f\u5f8c\u306e\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3084\u3001\u5b9f\u4e16\u754c\u30c7\u30fc\u30bf\uff08RE\uff09\u306e\u53ce\u96c6\u306b\u304a\u3044\u3066\u3082\u3001\u30c7\u30b8\u30bf\u30eb\u6280\u8853\u304c\u5f79\u7acb\u3064\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>

\u533b\u7642\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u4f01\u696d\u306b\u306f\u3001\u6210\u9577\u306e\u9053\u304c\u958b\u3051\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u3053\u3046\u3057\u305f\u4f01\u696d\u306f\u3001\u30ec\u30b8\u30b9\u30c8\u30ea\u3001\u81e8\u5e8a\u8a66\u9a13\u7ba1\u7406\u3001\u9060\u9694\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3001\u30c7\u30fc\u30bf\u306e\u76f8\u4e92\u904b\u7528\u6027\u3068\u3044\u3063\u305f\u5206\u91ce\u306b\u53d6\u308a\u7d44\u3080\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002.<\/p>

\u4f01\u696d\u306b\u3068\u3063\u3066\u306f\u3001\u3053\u308c\u304c\u30c1\u30fc\u30e0\u30ef\u30fc\u30af\u306e\u5f37\u5316\u306b\u3064\u306a\u304c\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u88fd\u85ac\u4f1a\u793e\u3001\u75c5\u9662\u3001\u5927\u5b66\u3001\u305d\u3057\u3066\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u30d7\u30ed\u30d0\u30a4\u30c0\u30fc\u304c\u3001\u4e92\u3044\u306b\u7dca\u5bc6\u306b\u9023\u643a\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308b\u3067\u3057\u3087\u3046\u3002.<\/p>

A Strong Signal for Japan’s Health-Tech Future<\/h3>

Takeda’s ORZEYFUL approval represents a development for Japan’s pharmaceutical industry and its wider technology ecosystem.<\/p>

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a CKD\u6cbb\u7642\u85ac\u5e02\u5834\u306f2035\u5e74\u307e\u3067\u306b$10.9B\u306b\u9054\u3057\u3001\u65e5\u672c\u306e\u30d8\u30eb\u30b9\u30c6\u30c3\u30af\u3092\u5f8c\u62bc\u3057\u3059\u308b<\/a><\/h4>

\u3053\u306e\u533b\u85ac\u54c1\u306f\u3001\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc1\u578b\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u6cd5\u3092\u63d0\u4f9b\u3059\u308b\u3068\u3068\u3082\u306b\u3001\u65e5\u672c\u3092\u62e0\u70b9\u3068\u3059\u308b\u795e\u7d4c\u79d1\u5b66\u7814\u7a76\u304c\u3001\u4e16\u754c\u7684\u306b\u610f\u7fa9\u306e\u3042\u308b\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u751f\u307f\u51fa\u3059\u53ef\u80fd\u6027\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u3053\u306e\u533b\u85ac\u54c1\u306e\u5546\u696d\u5316\u306f\u3001\u7814\u7a76\u6280\u8853\u3001\u533b\u7642\u7528\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3001\u533b\u7642\u30c7\u30fc\u30bf\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3001\u304a\u3088\u3073\u30c7\u30b8\u30bf\u30eb\u60a3\u8005\u652f\u63f4\u30b7\u30b9\u30c6\u30e0\u306b\u5bfe\u3059\u308b\u9700\u8981\u3092\u559a\u8d77\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>

\u65e5\u672c\u304c\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001AI\u3001\u30d8\u30eb\u30b9\u30b1\u30a2\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3078\u306e\u6295\u8cc7\u3092\u7d9a\u3051\u308b\u306b\u3064\u308c\u3001\u88fd\u85ac\u3068\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u306e\u5883\u754c\u7dda\u306f\u307e\u3059\u307e\u3059\u66d6\u6627\u306b\u306a\u3063\u3066\u3044\u304f\u3082\u306e\u3068\u601d\u308f\u308c\u307e\u3059\u3002.<\/p>

\u3057\u305f\u304c\u3063\u3066\u3001ORZEYFUL\u306f\u5358\u306a\u308b\u65e5\u672c\u5e02\u5834\u5411\u3051\u306e\u533b\u85ac\u54c1\u3068\u3044\u3046\u3060\u3051\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u3053\u308c\u306f\u3001\u65e5\u672c\u767a\u306e\u79d1\u5b66\u7684\u7814\u7a76\u304c\u3001\u3044\u304b\u306b\u6cbb\u7642\u6280\u8853\u3092\u5275\u51fa\u3057\u3001\u56fd\u5185\u306e\u30d8\u30eb\u30b9\u30b1\u30a2\u30fb\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u3092\u5f37\u5316\u3057\u3001\u533b\u85ac\u54c1\u3001\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u30c7\u30b8\u30bf\u30eb\u6280\u8853\u306e\u4ea4\u5dee\u70b9\u3067\u4e8b\u696d\u3092\u5c55\u958b\u3059\u308b\u4f01\u696d\u306b\u3068\u3063\u3066\u306e\u6a5f\u4f1a\u3092\u5275\u51fa\u3067\u304d\u308b\u304b\u3092\u793a\u3059\u597d\u4f8b\u3067\u3059\u3002.<\/p>","protected":false},"excerpt":{"rendered":"

Japans medicine and health technology industries are moving into a time of new ideas after the Japanese Ministry of Health Labour and Welfare approved a medicine called ORZEYFUL made by Takeda Pharmaceutical. This medicine is for adults who have a condition called narcolepsy type 1.The approval came out on August 24 2026. It is very important because ORZEYFUL is the medicine of its kind that is taken by mouth. It works on a part of the brain called the orexin receptor 2. This medicine helps with the root cause of the condition, which’s a lack of orexin. It does not just treat the symptoms. The medicine was created by scientists […]<\/p>\n","protected":false},"author":7,"featured_media":38293,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[89,8098],"tags":[314,15018,15019,575,8700],"ppma_author":[572],"class_list":["post-38269","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-tech","category-news-articles","tag-japan","tag-neurotech-industry","tag-orzeyful","tag-pharmaceutical","tag-takeda"],"yoast_head":"\nTakeda\u2019s ORZEYFUL Approval Signals Neurotech Growth<\/title>\n<meta name=\"description\" content=\"ORZEYFUL\u2019s approval by Takeda for Japan\u2019s neurotech sector, potentially encouraging new investment and innovation in neurological healthcare.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Takeda\u2019s ORZEYFUL Approval Signals Neurotech Growth\" \/>\n<meta property=\"og:description\" content=\"ORZEYFUL\u2019s approval by Takeda for Japan\u2019s neurotech sector, potentially encouraging new investment and innovation in neurological healthcare.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-26T12:17:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Takedas-Orzeyful-secured-Japan-MHLW-approval-for-narcolepsy-type-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"5\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6b66\u7530\u85ac\u54c1\u306e\u300cORZEYFUL\u300d\u306e\u627f\u8a8d\u306f\u3001\u30cb\u30e5\u30fc\u30ed\u30c6\u30c3\u30af\u5206\u91ce\u306e\u6210\u9577\u3092\u793a\u3059\u3082\u306e\u3067\u3059","description":"\u6b66\u7530\u85ac\u54c1\u306b\u3088\u308bORZEYFUL\u306e\u627f\u8a8d\u306f\u3001\u65e5\u672c\u306e\u30cb\u30e5\u30fc\u30ed\u30c6\u30c3\u30af\u5206\u91ce\u306b\u304a\u3044\u3066\u3001\u795e\u7d4c\u75be\u60a3\u533b\u7642\u5206\u91ce\u3078\u306e\u65b0\u305f\u306a\u6295\u8cc7\u3084\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u4fc3\u9032\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/","og_locale":"ja_JP","og_type":"article","og_title":"Takeda\u2019s ORZEYFUL Approval Signals Neurotech Growth","og_description":"ORZEYFUL\u2019s approval by Takeda for Japan\u2019s neurotech sector, potentially encouraging new investment and innovation in neurological healthcare.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/","og_site_name":"itbusinesstoday","article_published_time":"2026-08-26T12:17:14+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Takedas-Orzeyful-secured-Japan-MHLW-approval-for-narcolepsy-type-1.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"5\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Takeda\u2019s ORZEYFUL Approval Marks New Milestone for Japan\u2019s Neurotech Industry","datePublished":"2026-08-26T12:17:14+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/"},"wordCount":980,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Takedas-Orzeyful-secured-Japan-MHLW-approval-for-narcolepsy-type-1.webp","keywords":["Japan","Neurotech Industry","ORZEYFUL","pharmaceutical","Takeda"],"articleSection":["Health Tech","News Articles"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/","name":"\u6b66\u7530\u85ac\u54c1\u306e\u300cORZEYFUL\u300d\u306e\u627f\u8a8d\u306f\u3001\u30cb\u30e5\u30fc\u30ed\u30c6\u30c3\u30af\u5206\u91ce\u306e\u6210\u9577\u3092\u793a\u3059\u3082\u306e\u3067\u3059","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Takedas-Orzeyful-secured-Japan-MHLW-approval-for-narcolepsy-type-1.webp","datePublished":"2026-08-26T12:17:14+00:00","description":"\u6b66\u7530\u85ac\u54c1\u306b\u3088\u308bORZEYFUL\u306e\u627f\u8a8d\u306f\u3001\u65e5\u672c\u306e\u30cb\u30e5\u30fc\u30ed\u30c6\u30c3\u30af\u5206\u91ce\u306b\u304a\u3044\u3066\u3001\u795e\u7d4c\u75be\u60a3\u533b\u7642\u5206\u91ce\u3078\u306e\u65b0\u305f\u306a\u6295\u8cc7\u3084\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u4fc3\u9032\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Takedas-Orzeyful-secured-Japan-MHLW-approval-for-narcolepsy-type-1.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Takedas-Orzeyful-secured-Japan-MHLW-approval-for-narcolepsy-type-1.webp","width":1200,"height":800,"caption":"Takedas"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Takeda\u2019s ORZEYFUL Approval Marks New Milestone for Japan\u2019s Neurotech Industry"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/38269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=38269"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/38269\/revisions"}],"predecessor-version":[{"id":38270,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/38269\/revisions\/38270"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/38293"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=38269"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=38269"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=38269"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=38269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}